• 1
    Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74108.
  • 2
    Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006; 24: 213750.
  • 3
    World Health Organization. Cancer (Fact sheet N°297). February 2009. Retrieved 2009-05-11.
  • 4
    Roukos DH, Kappas AM. Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol 2005; 2: 98107.
  • 5
    StewartB, KleihuesP, eds. World cancer reported. Lyon: IARC Press, 2003.
  • 6
    Chan AO, Wong BC, Lam SK. Gastric cancer: past, present and future. Can J Gastroenterol 2001; 15: 46974.
  • 7
    Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, Negri E, Malvezzi M, La Vecchia C. Recent patterns in gastric cancer: a global overview. Int J Cancer 2009; 125: 66673.
  • 8
    Terry MB, Gaudet MM, Gammon MD. The epidemiology of gastric cancer. Semin Radiat Oncol 2002; 12: 11127.
  • 9
    Stadtlander CT, Waterbor JW. Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis 1999; 20: 2195208.
  • 10
    Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12: 35462.
  • 11
    Tatsuta M, Iishi H, Baba M, Taniguchi H. Enhancement of experimental gastric carcinogenesis induced in spontaneously hypertensive rats by N-methyl-N′-nitro-N-nitrosoguanidine. Cancer Res 1989; 49: 7948.
  • 12
    Tatsuta M, Iishi H, Baba M, Taniguchi H. Inhibition of azoxymethane-induced experimental colon carcinogenesis in Wistar rats by 6-hydroxydopamine. Int J Cancer 1992; 50: 298301.
  • 13
    Chakroborty D, Chowdhury UR, Sarkar C, Baral R, Dasgupta PS, Basu S. Dopamine regulates endothelial progenitor cell mobilization from mouse bone marrow in tumor vascularization. J Clin Invest 2008; 118: 13809.
  • 14
    Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M, Merritt WM, Lin YG, et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 2006; 12: 93944.
  • 15
    Lutgendorf SK, Cole S, Costanzo E, Bradley S, Coffin J, Jabbari S, Rainwater K, Ritchie JM, Yang M, Sood AK. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin Cancer Res 2003; 9: 451421.
  • 16
    Yang EV, Sood AK, Chen M, Li Y, Eubank TD, Marsh CB, Jewell S, Flavahan NA, Morrison C, Yeh PE, Lemeshow S, Glaser R. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res 2006; 66: 1035764.
  • 17
    Dvorak HF. Angiogenesis: update 2005. J Thromb Haemost 2005; 3: 183542.
  • 18
    Iishi H, Baba M, Tatsuta M, Okuda S, Taniguchi H. Enhancement of dopaminergic agonist bromocriptine of gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats. Br J Cancer 1992; 65: 3514.
  • 19
    Fitzgerald PJ. Is norepinephrine an etiological factor in some types of cancer? Int J Cancer 2009; 124: 25763.
  • 20
    Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 8607.
  • 21
    Wang WH, Huang JQ, Zheng GF, Lam SK, Karlberg J, Wong BC. Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. J Natl Cancer Inst 2003; 95: 178491.
  • 22
    Suleyman H, Cadirci E, Albayrak A, Halici Z. Nimesulide is a selective COX-2 inhibitory, atypical non-steroidal anti-inflammatory drug. Curr Med Chem 2008; 15: 27883.
  • 23
    Suleyman H, Halici Z, Cadirci E, Hacimuftuoglu A, Bilen H. Indirect role of beta(2)-adrenergic receptors in the mechanism of anti-inflammatory action of NSAIDs. J Physiol Pharmacol 2008; 59: 66172.
  • 24
    Suleyman H, Cadirci E, Albayrak A, Halici Z, Polat B, Hacimuftuoglu A, Alp HH. Reason for the aggravation of diseases caused by inflammation and the ineffectiveness of NSAIDs on these diseases in rainy weather. Pharmacol Rep 2009; 61: 5149.
  • 25
    Schimmer BP, Parker KL. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: BruntonLL, ed. Goodmann and Gilmans the pharmacological basis of therapeutics. New York: McGraw-Hill, 2006. 1587612.
  • 26
    Suleyman H, Halici Z, Cadirci E, Hacimuftuoglu A, Keles S, Gocer F. Indirect role of alpha2-adrenoreceptors in anti-ulcer effect mechanism of nimesulide in rats. Naunyn Schmiedebergs Arch Pharmacol 2007; 375: 18998.
  • 27
    Black HE. The effects of steroids upon the gastrointestinal tract. Toxicol Pathol 1988; 16: 21322.
  • 28
    Wallace JL. Glucocorticoid-induced gastric mucosal damage: inhibition of leukotriene, but not prostaglandin biosynthesis. Prostaglandins 1987; 34: 31123.
  • 29
    Weusten BL, Jacobs JW, Bijlsma JW. Corticosteroid pulse therapy in active rheumatoid arthritis. Semin Arthritis Rheum 1993; 23: 18392.
  • 30
    Iishi H, Tatsuta M, Baba M, Sakai N, Yano H, Uehara H, Nakaizumi A, Iseki K. Promotion by the alpha-adrenoceptor agonist phenylephrine, but not by the beta-adrenoceptor agonist isoproterenol, of gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats. Cancer Lett 1998; 122: 615.
  • 31
    Sugimura T, Terada M. Experimental chemical carcinogenesis in the stomach and colon. Jpn J Clin Oncol 1998; 28: 1637.
  • 32
    Herr I, Pfitzenmaier J. Glucocorticoid use in prostate cancer and other solid tumours: implications for effectiveness of cytotoxic treatment and metastases. Lancet Oncol 2006; 7: 42530.
  • 33
    Wu CW, Chang YF, Yeh TH, Chang TJ, Lui WY, P'Eng FK, Chi CW. Steroid hormone receptors in three human gastric cancer cell lines. Dig Dis Sci 1994; 39: 268994.
  • 34
    Lui WY, P'Eng FK, Chang YF, Chang TJ, Tsai TF, Hsu ML, Su TS, Tsay SH, Wu CW, Liu TY, Chi CW. Analysis of glucocorticoid receptors in human hepatocellular carcinoma and HepG2 cells. Hepatology 1993; 18: 116774.
  • 35
    Berrada A, Denis MG, Blanchardie P, Chadeneau C, Lustenberger P. Glucocorticoid effects and receptors in two rat colon carcinoma cell lines differing by their tumorigenicity. J Steroid Biochem Mol Biol 1990; 37: 22330.
  • 36
    Lointier P, Wildrick DM, Boman BM. The effects of steroid hormones on a human colon cancer cell line in vitro. Anticancer Res 1992; 12: 132730.
  • 37
    Yoshida Y, Kishimoto T, Ishiguro H, Nagai Y, Koda K, Takiguchi N, Miyazaki M, Ishikura H. Dexamethasone modifies the susceptibility to serum cytotoxicity and increases the metastatic efficiency of a colon carcinoma cell line. Exp Mol Pathol 2006; 81: 7784.
  • 38
    Zhang C, Kolb A, Mattern J, Gassler N, Wenger T, Herzer K, Debatin KM, Buchler M, Friess H, Rittgen W, Edler L, Herr I. Dexamethasone desensitizes hepatocellular and colorectal tumours toward cytotoxic therapy. Cancer Lett 2006; 242: 10411.
  • 39
    Evers BM, Thompson EB, Townsend CM Jr, Lawrence JL, Johnson B, Srinivasan G, Thompson JC. Cortivazol increases glucocorticoid receptor expression and inhibits growth of hamster pancreatic cancer (H2T) in vivo. Pancreas 1993; 8: 714.
  • 40
    Alford TC, Do HM, Geelhoed GW, Tsangaris NT, Lippman ME. Steroid hormone receptors in human colon cancers. Cancer 1979; 43: 9804.
  • 41
    Theocharis S, Kouraklis G, Margeli A, Agapitos E, Ninos S, Karatzas G, Koutselinis A. Glucocorticoid receptor (GR) immunohistochemical expression is correlated with cell cycle-related molecules in human colon cancer. Dig Dis Sci 2003; 48: 174550.
  • 42
    Wu CW, Wang SR, Chang TJ, Lin EC, Chang KL, Huang MH, Lui WY, P'Eng FK, Chi CW. Content of glucocorticoid receptor and arginase in gastric cancer and normal gastric mucosal tissues. Cancer 1989; 64: 25526.
  • 43
    Krelenbaum M, Kareem AM, Fleiszer D, Fazekas AG. Steroid hormone receptors in dimethylhydrazine-induced rat colonic tumors. Anticancer Res 1984; 4: 3958.
  • 44
    Ushijima I, Mizuki Y, Yamada M. The mode of action of bromocriptine following pretreatment with reserpine and alpha-methyl-p-tyrosine in rats. Psychopharmacology (Berl) 1988; 95: 2933.
  • 45
    Hoffman BB. Therapy of hypertension. In: BruntonLL, ed. Godman and Gilman's the pharmacological basis of therapeutics. New-York: Mc Graw-Hill, 2006. 84597.
  • 46
    Crassous PA, Denis C, Paris H, Senard JM. Interest of alpha2-adrenergic agonists and antagonists in clinical practice: background, facts and perspectives. Curr Top Med Chem 2007; 7: 18794.
  • 47
    Tatsuta M, Iishi H, Baba M, Yano H, Sakai N, Uehara H, Hirasawa R, Nakaizumi A. Alpha1-adrenoceptor stimulation enhances experimental gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats. Int J Cancer 1998; 77: 4679.
  • 48
    Tatsuta M, Iishi H, Baba M, Taniguchi H. Enhanced induction of gastric carcinogenesis by N-methyl-N′-nitro-N-nitrosoguanidine in deoxycorticosterone acetate-NaCl hypertensive rats and its inhibition by potassium chloride. Cancer Res 1991; 51: 28636.